Resverlogix Corp.
  • About
    • Overview
    • Team
    • Partnership Strategy
    • Governance
  • Science & Programs
    • BETonMACE
    • Epigenetics
    • Apabetalone
    • Clinical
    • Publications
  • Investors
    • Financial Reports
    • News
    • Presentations & Events
  • Articles & Media
    • Featured Stories
    • From the Archives
  • Contact
    • General
    • Careers
RVX $0.10 -$0.01

Investors

  1. Home
  2. Investors
  3. News

News

To receive future news releases direct to your inbox, subscribe by emailing ir@resverlogix.com.

Historical news and financial information can also be found at www.sedarplus.ca under the Company’s profile.

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A
March 17, 2026
Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement
February 18, 2026
  • Financial Reports
  • News
  • Presentations & Events
Fact Sheet Request Info Presentation
About
  • Overview
  • Team
  • Partnership Strategy
  • Governance
Science & Programs
  • BETonMACE
  • Epigenetics
  • Apabetalone
  • Clinical
  • Publications
Investors
  • Financial Reports
  • News
  • Presentations & Events
Articles & Media
  • Featured Stories
  • From the Archives
Contact
  • General
  • Careers
  • Contact
  • Glossary
  • Sitemap
  • Legal